Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:9
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [21] Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy
    Taniyama, Yusuke
    Sakurai, Tadashi
    Heishi, Takahiro
    Okamoto, Hiroshi
    Sato, Chiaki
    Maruyama, Shota
    Onodera, Yu
    Ishida, Hirotaka
    Unno, Michiaki
    Kamei, Takashi
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1554 - 1562
  • [22] Risk factors for anastomotic leakage after surgical resections for esophageal cancer
    Herzberg, Jonas
    Strate, Tim
    Guraya, Salman Yousuf
    Honarpisheh, Human
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (06) : 1859 - 1866
  • [23] Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study
    Lin, Chen-Yuan
    Lien, Ming-Yu
    Chen, Chi-Ching
    Fang, Hsin-Yuan
    Lin, Yu-Sen
    Chen, Chien-Kuang
    Chen, Jian-Xun
    Lu, Ting-Yu
    Huang, Tzu-Min
    Hsieh, Te-Chun
    Sun, Shung-Shung
    Li, Chia-Chin
    Chien, Chun-Ru
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [24] Esophageal Cancer: Surgical Strategies
    Costa, Paulo
    Esteves, Rui
    Lages, Patrcia
    Ferreira, Filipa
    ACTA MEDICA PORTUGUESA, 2014, 27 (05): : 593 - 600
  • [25] Definitive chemoradiotherapy for esophageal cancer: 66 Gy versus 50 Gy, a retrospective study
    Clavier, J. -B.
    Antoni, D.
    Atlani, D.
    Ben Abdelghani, M.
    Schumacher, C.
    Salze, P.
    Noel, G.
    CANCER RADIOTHERAPIE, 2013, 17 (03): : 221 - 228
  • [26] Prognostic Impact of Postoperative Complications following Salvage Esophagectomy for Esophageal Cancer after Definitive Chemoradiotherapy
    Sugimura, Keijiro
    Miyata, Hiroshi
    Shinno, Naoki
    Ushigome, Hajime
    Asukai, Kei
    Hara, Hisashi
    Hasegawa, Shinichiro
    Yamada, Daisaku
    Yamamoto, Kazuyoshi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Motoori, Masaaki
    Wada, Hiroshi
    Takahashi, Hidenori
    Yasui, Masayoshi
    Omori, Takeshi
    Ohue, Masayuki
    Yano, Masahiko
    ONCOLOGY, 2020, 98 (05) : 280 - 288
  • [27] Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer
    Liu, Jing
    Yue, Jinbo
    Xing, Ligang
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2013, 7 (02) : 172 - 179
  • [28] Salvage Lymphadenectomy for Recurrent Esophageal Cancer After Chemoradiotherapy
    Nakajima, Masanobu
    Domeki, Yasushi
    Satomura, Hitoshi
    Takahashi, Masakazu
    Sugawara, Akira
    Muroi, Hiroto
    Sasaki, Kinro
    Yamaguchi, Satoru
    Miyazaki, Tatsuya
    Kuwano, Hiroyuki
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2014, 99 (04) : 452 - 457
  • [29] Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy
    Molena, D.
    Sun, H. H.
    Badr, A. S.
    Mungo, B.
    Sarkaria, I. S.
    Adusumilli, P. S.
    Bains, M. S.
    Rusch, V. W.
    Ilson, D. H.
    Rizk, N. P.
    DISEASES OF THE ESOPHAGUS, 2014, 27 (04) : 355 - 359
  • [30] Estimation of physiologic ability and surgical stress (E-PASS) can assess short-term outcome after esophagectomy for esophageal cancer
    Yoshida, Naoya
    Watanabe, Masayuki
    Baba, Yoshifumi
    Iwagami, Shiro
    Ishimoto, Takatsugu
    Iwatsuki, Masaaki
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Ozaki, Nobuyuki
    Baba, Hideo
    ESOPHAGUS, 2013, 10 (02) : 86 - 94